Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 172

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Cancer-related and treatment-related fatigue

Open access
Wang, Xin Shelley, Woodruff, Jeanie F. · 2015 · Gynecologic Oncology

Abstract

Fatigue is a distressing and persistent symptom for patients with gynecological cancer and for survivors. Debilitating cancer-related fatigue (CRF) is produced by both the disease and its treatment. Although awareness and study of CRF have grown in recent years, consistent assessment has not been a priority in routine medical practice. The pathophysiological mechanisms that induce CRF remain unclear, and effective pharmacological interventions have yet to be established. Based on the literature and our own research results, this review focuses on recent progress toward understanding the nature and causes of CRF and on several promising treatment modalities. Given the prevalence and severity of CRF in the gynecological cancer patient population, establishing standardized fatigue measurement and management methods in routine clinical oncology care is of utmost importance. Whether CRF has an underlying inflammatory cause is still hypothetical, however, and no mechanism-driven symptom intervention is currently in clinical use, even though the development of such interventions would provide patients with greater symptom control. Advancing translational and clinical fatigue research will require anatomical pathway studies and well-designed clinical investigations that focus on the development of mechanism-driven interventions based on physiological–behavioral fatigue research, implementation of guidelines for experimental designs, and discovery of biomarkers identifying individuals at high risk for CRF. Validated patient-reported outcomes measures are an essential component of such clinical studies. Because numerous subscales, unidimensional measures, and multidimensional measures exist, clinicians and researchers should consider individual circumstances, good clinical practice, and research goals as guides for choosing the most appropriate fatigue measurement tool. Additionally, education about CRF should be made available to all patients and their caregivers, as accurate and age-appropriate information about conditions like CRF can alleviate much of the stress and anxiety brought on by poor communication about this distressing condition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ygyno.2014.10.013

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 59

  1. Mendoza, 1999, The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory, Cancer, 85, 1186, 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N · DOI
  2. Servaes, 2007, The course of severe fatigue in disease-free breast cancer patients: a longitudinal study, Psychooncology, 16, 787, 10.1002/pon.1120 · DOI · Paper page
  3. Wang, 2014, Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors, Cancer, 120, 425, 10.1002/cncr.28434 · DOI · Paper page
  4. Alvarez, 2014, A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study, Gynecol Oncol, 133, 433, 10.1016/j.ygyno.2014.03.571 · DOI
  5. Martin, 2014, A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study, Gynecol Oncol, 132, 526, 10.1016/j.ygyno.2013.12.018 · doi:10.1016/j.ygyno.2013.12.018
  6. Anderson, 2008, Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors, Clin J Oncol Nurs, 12, 445, 10.1188/08.CJON.445-454 · doi:10.1188/08.cjon.445-454
  7. Williams, 2013, Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer, J Pain Symptom Manage, 46, 837, 10.1016/j.jpainsymman.2013.02.007 · DOI
  8. Sailors, 2013, Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer, Gynecol Oncol, 130, 323, 10.1016/j.ygyno.2013.05.009 · DOI
  9. Barsevick, 2010, ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials, J Pain Symptom Manage, 39, 1086, 10.1016/j.jpainsymman.2010.02.006 · DOI
  10. Mock, 2007, Cancer-related fatigue. Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 5, 1054, 10.6004/jnccn.2007.0088 · DOI · Paper page
  11. Wang, 2008, Pathophysiology of cancer-related fatigue, Clin J Oncol Nurs, 12, 11, 10.1188/08.CJON.S2.11-20 · DOI
  12. Given, 2001, Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients, J Pain Symptom Manage, 21, 456, 10.1016/S0885-3924(01)00284-6 · DOI · Paper page
  13. Peters, 2014, Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients, J Neurooncol, 10.1007/s11060-014-1574-3 · DOI
  14. Wang, 2006, Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms, J Clin Oncol, 24, 4485, 10.1200/JCO.2006.07.1126 · DOI
  15. Minton, 2012, Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set, J Pain Symptom Manage, 43, 226, 10.1016/j.jpainsymman.2011.03.025 · DOI
  16. Rubin, 2002, Systematic review and meta-analysis of interventions for postoperative fatigue, Br J Surg, 89, 971, 10.1046/j.1365-2168.2002.02138.x · DOI
  17. Shi, 2011, Symptom burden in cancer survivors 1year after diagnosis: a report from the American Cancer Society's Studies of cancer survivors, Cancer, 117, 2779, 10.1002/cncr.26146 · DOI · Paper page
  18. Téllez, 2008, The basal ganglia: a substrate for fatigue in multiple sclerosis, Neuroradiology, 50, 17, 10.1007/s00234-007-0304-3 · DOI
  19. Cleeland, 2003, Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?, Cancer, 97, 2919, 10.1002/cncr.11382 · DOI · Paper page
  20. Wang, 2008, Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation, Cancer, 113, 2102, 10.1002/cncr.23820 · DOI
  21. Sprangers, 2014, Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update, Qual Life Res, 23, 1997, 10.1007/s11136-014-0656-1 · DOI
  22. Whistler, 2006, Gene expression correlates of unexplained fatigue, Pharmacogenomics, 7, 395, 10.2217/14622416.7.3.395 · DOI
  23. Bower, 2011, Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue, Brain Behav Immun, 25, 147, 10.1016/j.bbi.2010.09.010 · DOI · Paper page
  24. Collado-Hidalgo, 2006, Inflammatory biomarkers for persistent fatigue in breast cancer survivors, Clin Cancer Res, 12, 2759, 10.1158/1078-0432.CCR-05-2398 · DOI · Paper page
  25. Schubert, 2007, The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review, Brain Behav Immun, 21, 413, 10.1016/j.bbi.2006.11.004 · DOI · Paper page
  26. Bower, 2011, Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?, J Clin Oncol, 29, 3517, 10.1200/JCO.2011.36.1154 · DOI · Paper page
  27. Wang, 2012, Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy, Brain Behav Immun, 26, 699, 10.1016/j.bbi.2011.12.007 · DOI
  28. Inagaki, 2008, Plasma interleukin-6 and fatigue in terminally ill cancer patients, J Pain Symptom Manage, 35, 153, 10.1016/j.jpainsymman.2007.03.009 · DOI
  29. Laird, 2013, The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer, Oncologist, 18, 1050, 10.1634/theoncologist.2013-0120 · DOI
  30. Irwin, 2007, Depressive disorders and immunity: 20years of progress and discovery, Brain Behav Immun, 21, 374, 10.1016/j.bbi.2007.01.010 · DOI · Paper page
  31. Payne, 2011, Altered circadian rhythms and cancer-related fatigue outcomes, Integr Cancer Ther, 10, 221, 10.1177/1534735410392581 · DOI
  32. Atkinson, 2012, Reliability of adverse symptom event reporting by clinicians, Qual Life Res, 21, 1159, 10.1007/s11136-011-0031-4 · DOI · Paper page
  33. Basch, 2009, Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes, J Natl Cancer Inst, 101, 1624, 10.1093/jnci/djp386 · DOI · Paper page
  34. Olson, 2007, A new way of thinking about fatigue: a reconceptualization, Oncol Nurs Forum, 34, 93, 10.1188/07.ONF.93-99 · DOI
  35. Cleeland, 1999, Measuring and understanding fatigue, Oncology, 13, 91
  36. Hjollund, 2007, Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales, Health Qual Life Outcomes, 5, 12, 10.1186/1477-7525-5-12 · DOI · Paper page
  37. Wang, 2010, Impact of cultural and linguistic factors on symptom reporting by patients with cancer, J Natl Cancer Inst, 102, 732, 10.1093/jnci/djq097 · DOI
  38. Lai, 2006, Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue, Qual Life Res, 15, 1179, 10.1007/s11136-006-0060-6 · DOI
  39. Krupp, 1989, The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus, Arch Neurol, 46, 1121, 10.1001/archneur.1989.00520460115022 · DOI · Paper page
  40. Smets, 1995, The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue, J Psychosom Res, 39, 315, 10.1016/0022-3999(94)00125-O · DOI · Paper page
  41. Ho, 2014, Cancer-related fatigue in breast cancer patients: factor mixture models with continuous non-normal distributions, Qual Life Res, 10.1007/s11136-014-0731-7 · DOI
  42. Serlin, 1995, When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function, Pain, 61, 277, 10.1016/0304-3959(94)00178-H · DOI · Paper page
  43. Cleeland, 1994, Pain and its treatment in outpatients with metastatic cancer, N Engl J Med, 330, 592, 10.1056/NEJM199403033300902 · DOI · Paper page
  44. Fisch, 2014, Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors, Cancer, 120, 442, 10.1002/cncr.28437 · DOI
  45. Denlinger, 2014, Survivorship: fatigue, version 1.2014, J Natl Compr Canc Netw, 12, 876, 10.6004/jnccn.2014.0082 · DOI
  46. De La Cruz, 2010, Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer, Cancer, 116, 766, 10.1002/cncr.24751 · DOI
  47. Minton, 2011, Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis, J Pain Symptom Manage, 41, 761, 10.1016/j.jpainsymman.2010.06.020 · DOI
  48. Gong, 2014, Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis, PLoS One, 9, e84391, 10.1371/journal.pone.0084391 · DOI
  49. Paulsen, 2014, Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial, J Clin Oncol, 10;32, 3221, 10.1200/JCO.2013.54.3926 · DOI · Paper page
  50. Jean-Pierre, 2010, Cancer, 116, 3513, 10.1002/cncr.25083 · DOI · Paper page
  51. Spathis, 2014, Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial, J Clin Oncol, 32, 1882, 10.1200/JCO.2013.54.4346 · DOI
  52. Roscoe, 2005, Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy, Breast Cancer Res Treat, 89, 243, 10.1007/s10549-004-2175-1 · DOI · Paper page
  53. Moss, 2006, An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners, Psychooncology, 15, 259, 10.1002/pon.952 · DOI
  54. Barton, 2013, Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2, J Natl Cancer Inst, 105, 1230, 10.1093/jnci/djt181 · DOI · Paper page
  55. Su, 2014, Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials, Complement Ther Med, 22, 567, 10.1016/j.ctim.2014.04.007 · DOI
  56. Jacobsen, 2007, Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue, Health Psychol, 26, 660, 10.1037/0278-6133.26.6.660 · DOI · Paper page
  57. Markes, 2006, Exercise for women receiving adjuvant therapy for breast cancer, Cochrane Database Syst Rev, CD005001
  58. Mustian, 2007, Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue, Oncologist, 12, 52, 10.1634/theoncologist.12-S1-52 · DOI · Paper page
  59. George, 2014, Better postdiagnosis diet quality is associated with less cancer-related fatigue in breast cancer survivors, J Cancer Surviv, 10.1007/s11764-014-0381-3 · DOI

Cited by

See all 172

Metadata

Authors
Wang, X. S., & Woodruff, J. F.
Venue
Gynecologic Oncology
Publisher
Elsevier BV
Published
2015-03
Volume
136
Issue
3
Pages
446-452
ISSN
0090-8258 (ISSN-L)
OpenAlex
W2055366832
Cited by
172
References
8
FWCI
4.16
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
National Institutes of Health (R21 CA158902)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer-related and treatment-related fatigue. https://app.cochat.ai/papers/10.1016/j.ygyno.2014.10.013
The paper
Wang, X. S., & Woodruff, J. F. (2015). Cancer-related and treatment-related fatigue. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2014.10.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.